Multivariate analysis showed that the HCC imaging no-show rate and HCC imaging delay remained independent risk factors for TTP when accounting for Milan criteria, AFP levels, albumin levels, and first-cycle LDT response rates, regardless of transplant track status (Table 6). This evidence concerns the gene ALB and hepatocellular carcinoma.